Senna S
Senna S is an FDA drug label for the active ingredient DOCUSATE SODIUM, SENNOSIDES manufactured by Magno-Humphries, Inc. administered by ORAL. This page reproduces the FDA-approved indications and usage, dosage, contraindications, warnings, and adverse reactions exactly as published in the drug label. Data source: openFDA (U.S. FDA), label effective 20231027.
Generic: DOCUSATE SODIUM, SENNOSIDES
Manufacturer: Magno-Humphries, Inc.
Product Type: HUMAN OTC DRUG
Route: ORAL
Dosage Form:
NDC: 54257-089
Application: M007
Effective: 20231027
Active Ingredients: Active ingredients (in each tablet) Docusate sodium 50 mg Sennosides 8.6 mg Purpose Stool softener Stimulant laxative
Indications & Usage
Uses relieves occasional constipation (irregularity) generally produces bowel movement in 6 to 12 hours
Dosage & Administration
Directions Take only by mouth. Doses may be taken as a single daily dose, preferably in the evening, or in divided doses. adults and children 12 years and over take 2-4 tablets daily children 6 to under 12 years of age take 1-2 tablets daily children 2 to under 6 years of age take up to 1 tablet daily children under 2 ask a doctor
Contraindications
Not available.
Warnings
Warnings Do not use laxative products for longer than 1 week unless told do to so by a doctor if you are presently taking mineral oil unless told do to so by a doctor Ask a doctor before use if you have stomach pain nausea vomiting noticed a sudden change in bowel habits that lasts over 2 weeks Stop use and ask a doctor if you have rectal bleeding or fail to have a bowel movement after use of a laxative. These could be signs of a serious condition. If pregnant or breast-feeding, ask a health professional before use. Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center (1-800-222-1222) right away.
Adverse Reactions
Not available.
More from same ingredient
Sankaijo
Sato Pharmaceutical Co., Ltd.